Details of the Drug Reposition

General Information of This Drug (ID: DMSW80U)

Drug Name
VM-202   DMSW80U

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Peripheral neuropathy DIS7KN5G 8C0Z Phase 3 [1]
Angina pectoris DISCLMC4 BA40 Phase 3 [2]
Peripheral arterial disease DIS78WFB BD4Z Phase 3 [3]
Diabetic foot ulcer DISXVPHM BD54 Phase 3 [4]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Amyotrophic lateral sclerosis DISF7HVM 8B60.0 Phase 2 [5]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02427464) Phase 3 Gene Therapy for Painful Diabetic Neuropathy. U.S. National Institutes of Health.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)